TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial.

Jieyun Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.